Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ

B Mangla, P Mittal, P Kumar, S Javed, W Ahsan… - …, 2024 - Future Medicine
Aims: This study was aimed to formulate erlotinib (ERL)-loaded transferosomal gel (ERL@
TG) intended for topical application for the treatment of ductal carcinoma in situ. Materials & …
相关文章

Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ

B Mangla, P Mittal, P Kumar, S Javed… - Nanomedicine …, 2024 - pubmed.ncbi.nlm.nih.gov
Aims: This study was aimed to formulate erlotinib (ERL)-loaded transferosomal gel (ERL@
TG) intended for topical application for the treatment of ductal carcinoma in situ. Materials & …

Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ.

B Mangla, P Mittal, P Kumar, S Javed… - Nanomedicine …, 2024 - europepmc.org
Aims: This study was aimed to formulate erlotinib (ERL)-loaded transferosomal gel (ERL@
TG) intended for topical application for the treatment of ductal carcinoma in situ. Materials & …

Development of Erlotinib-Loaded Nanotransferosomal Gel for the Topical Treatment of Ductal Carcinoma in Situ

B Mangla, P Mittal, P Kumar, S Javed, W Ahsan… - …, 2024 - Taylor & Francis
Aims: This study was aimed to formulate erlotinib (ERL)-loaded transferosomal gel (ERL@
TG) intended for topical application for the treatment of ductal carcinoma in situ. Materials & …